Comera Life Sciences Holdings, Inc. Annual Operating Income (Loss) in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Comera Life Sciences Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2022.
  • Comera Life Sciences Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$2.16M, a 14.9% increase year-over-year.
  • Comera Life Sciences Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$9.15M.
  • Comera Life Sciences Holdings, Inc. annual Operating Income (Loss) for 2022 was -$12M, a 116% decline from 2021.
  • Comera Life Sciences Holdings, Inc. annual Operating Income (Loss) for 2021 was -$5.54M, a 160% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$12M -$6.43M -116% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-17
2021 -$5.54M -$3.41M -160% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 -$2.13M Jan 1, 2020 Dec 31, 2020 8-K 2022-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.